Hodges Capital Management Inc. Amgen Inc Transaction History

Hodges Capital Management Inc.

$1.5 Billion
Q3 2024

A detailed history of Hodges Capital Management Inc. transactions in Amgen Inc stock. As of the latest transaction made, Hodges Capital Management Inc. holds 15,672 shares of AMGN stock, worth $4.13 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

15,672

Previous 17,215 8.96%

Holding current value

$4.13 Million

Previous $5.38 Million 6.12%

% of portfolio

0.34%

Previous 0.37%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$309.38 - $337.38 $477,373 - $520,577	-1,543 Reduced 8.96%	15,672 $5.05 Million
Q2 2024 Aug 02, 2024	SELL	$262.75 - $319.31 $256,706 - $311,965	-977 Reduced 5.37%	17,215 $5.38 Million
Q1 2024 Apr 16, 2024	SELL	$268.87 - $324.56 $274,247 - $331,051	-1,020 Reduced 5.31%	18,192 $5.17 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $396,335 - $447,112	1,550 Added 8.78%	19,212 $5.53 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $565,647 - $702,267	-2,587 Reduced 12.78%	17,662 $4.75 Million
Q2 2023 Aug 04, 2023	SELL	$214.27 - $253.37 $721,447 - $853,096	-3,367 Reduced 14.26%	20,249 $4.74 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $676,241 - $824,224	2,995 Added 14.52%	23,616 $4.81 Million
Q4 2022 Feb 03, 2023	BUY	$229.03 - $291.01 $4.72 Million - $6 Million	20,621 New	20,621 $5.42 Million
Q2 2022 Jul 28, 2022	SELL	$230.71 - $256.74 $202,101 - $224,904	-876 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $192,080 - $212,491	876 New	876 $212,000
Q3 2021 Oct 06, 2021	SELL	$212.27 - $248.7 $184,887 - $216,617	-871 Closed	0 $0
Q2 2021 Jul 06, 2021	BUY	$233.58 - $259.14 $203,448 - $225,710	871 New	871 $212,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hodges Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hodges Capital Management Inc. with notifications on news.

Account

Hodges Capital Management Inc. Amgen Inc Transaction History